Methods for large-scale production of recombinant AAV vectors
AssigneeUniversity of Florida Research Foundation, Inc.
InventorsBarry J. Byrne, James E. Conway, Gary S. Hayward, Nicholas Muzyzcka, Sergei Zolotukhin
Life of this patent
Estimating the term…
Abstract
Disclosed are HSV-1 amplicons that supply all necessary helper functions required for rAAV packaging and methods for their use. These HSV-1 amplicons have been shown to be capable of rescuing and replicating all forms of rAAV genomes including rAAV genomes introduced into cells by infection of rAAV virions, rAAV genomes transfected into cells on plasmids or proviral rAAV genomes integrated into cellular chromosomal DNA. Also provided are methods for preparing high-titer rAAV vector compositions suitable for gene therapy and the delivery of exogenous polynucleotides to selected host cells.
Claims8
A recombinant herpes simplex virus ICP27 deletion mutant, rHSV d27.1rc, deposited with the American Type Culture Collection as Accession Number PTA-4004.
Dependencies are inferred from the claim text.